IOVA CLASS ACTION NOTICE: Iovance Biotherapeutics, Inc. has - GlobeNewswire
15 hours ago • Google News
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic m.
15 hours ago • Google News